Baroda BNP Paribas Health and Wellness Fund Direct Growth
1Y returns
—
cat 3.20%3Y CAGR
—
cat 23.13%5Y CAGR
—
cat 13.73%Std deviation 3Y
—
cat 16.46%In plain English
Baroda BNP Paribas Health and Wellness Fund Direct Growth is a Sectoral / Thematic scheme from Baroda BNP Paribas. The portfolio is ~96% in equities. Worst historical drawdown: -11% in Jan 2026, recovered in 4 months. Wrong fit if you need this money in less than 7 years.
Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.
NAV history
NAV (Direct-Growth)
₹10.4118
Last 1Y
+3.99%
Drawdown stories
The crashes you should know about — and how long the fund took to recover.
Jan 2026
-11.1%Peak ₹10.19 on 30 Jul 2025 → trough ₹9.06 on 29 Jan 2026 (6 months down).
Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.
Honesty score
A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.
Honesty score
4 / 5
Solid scheme on the dimensions we check. No red flags.
Expense ratio
0.60% — well below typical 1% for equity.
AUM size
₹515 Cr.
Sector concentration
Top 3 sectors = 95.9% — heavy concentration risk.
Performance
Returns for various periods, with category average and peer rank.
Portfolio composition
Asset allocation
- Equity95.92%
- Cash4.08%
By market cap
- Large cap29.18%
- Mid cap32.43%
- Small cap29.64%
- Others8.75%
Concentration
Holdings
34
Avg market cap
₹60.2K Cr
Top 10 stocks
52.23%
Top 5 stocks
32.66%
Top 3 sectors
95.92%
Top holdings
Top 15 positions by weight, latest disclosure.
- 1—10.23%
Sun Pharmaceuticals Industries Ltd
- 2—6.29%
Lupin Ltd
- 3—5.53%
Abbott India Ltd
- 4—5.32%
Torrent Pharmaceuticals Ltd
- 5—5.28%
Ipca Laboratories Ltd
- 6—4.52%
Clearing Corporation Of India Ltd
- 7—4.43%
Laurus Labs Ltd
- 8—4.41%
J.B. Chemicals & Pharmaceuticals Ltd
- 9—3.92%
AstraZeneca Pharma India Ltd
- 10—3.45%
SBI Life Insurance Co Ltd
- 11—3.36%
Emcure Pharmaceuticals Ltd
- 12—3.25%
Aster DM Healthcare Ltd Ordinary Shares
- 13—3.24%
Apollo Hospitals Enterprise Ltd
- 14—3.09%
Fortis Healthcare Ltd
- 15—2.96%
Gland Pharma Ltd
Fundamentals (vs category)
Portfolio-weighted ratios, compared with the category average.
- P/E ratio40.9239.01+1.91
- P/B ratio6.565.58+0.98
- Price / Sales4.505.22-0.72
- Price / Cash Flow30.9328.70+2.23
- Dividend yield0.73%0.67%+0.06
- Return on equity (ROE)—0.00%—
Risk metrics
Standard deviation, Sharpe, Sortino, Beta — all vs category average.
- ———12.6216.4615.45
Standard deviation
Volatility — lower means steadier returns.
- ———-0.230.960.61
Sharpe ratio
Risk-adjusted return — higher is better.
- ———-0.291.701.00
Sortino ratio
Like Sharpe but only counts downside volatility.
- ———0.930.950.92
Beta
1 = moves with the market. <1 = less volatile.
Peers in Sectoral / Thematic
Other schemes in the same SEBI category, ranked by AUM.
- ₹36.5K Cr+6.58%+22.72%0.57%
ICICI Prudential India Opportunities Fund
ICICI Prudential
- ₹36.5K Cr+1.48%+18.90%0.57%
ICICI Prudential India Opportunities Fund
ICICI Prudential
- ₹15.8K Cr+6.72%+21.95%0.64%
ICICI Prudential Business Cycle Fund Direct Plan Growth
ICICI Prudential
- ₹15.8K Cr+2.38%+18.99%0.64%
ICICI Prudential Business Cycle Fund Direct Plan Growth
ICICI Prudential
- ₹13.4K Cr-10.00%+10.76%0.86%
ICICI Prudential Technology Fund
ICICI Prudential
- ₹13.4K Cr-21.09%+5.76%0.86%
ICICI Prudential Technology Fund
ICICI Prudential
- ₹10.6K Cr+1.41%+13.88%0.87%
ICICI Prudential Banking and Financial Services Fund
ICICI Prudential
- ₹10.6K Cr-1.94%+11.58%0.87%
ICICI Prudential Banking and Financial Services Fund
ICICI Prudential
Available plans & options
- DirectGrowthBaroda BNP Paribas Health and Wellness Fund Direct GrowthINF251K01VA5
NEW
See your SIP through Indian market history
Pick a fund and a start year — get a 60-second cinematic replay of every crash, boom, and headline with your money in it. Real NAV data, no “assumed 12%” lies.
Try Wealth Time MachineAI · Free
Find what's really inside your funds
Upload your CAS PDF — get instant stock concentration, hidden fund overlap, sector risk, and 3 specific actions, written by AI in plain English.
Run Portfolio X-Ray